2023-03-30T16:58:22+08:00 weekly 1.0 https://srcyrl.prisysbiotech.com/ 2024-11-08T17:31:08+08:00 weekly 0.9 https://srcyrl.prisysbiotech.com/metabolic-syndromes-research 2024-11-08T17:31:05+08:00 weekly 0.9 https://srcyrl.prisysbiotech.com/respiratory-disease-research 2024-11-08T17:36:37+08:00 weekly 0.9 https://srcyrl.prisysbiotech.com/ophthalmic-disease-research 2024-11-08T17:31:12+08:00 weekly 0.9 https://srcyrl.prisysbiotech.com/hematological-disease-research 2024-11-08T17:36:41+08:00 weekly 0.9 https://srcyrl.prisysbiotech.com/cns-disorders-behavior-analysis 2024-11-08T17:31:22+08:00 weekly 0.9 https://srcyrl.prisysbiotech.com/inflammation-immunology-disorders 2024-11-08T23:58:48+08:00 weekly 0.9 https://srcyrl.prisysbiotech.com/animal-welfare 2023-04-01T22:11:38+08:00 weekly 0.9 https://srcyrl.prisysbiotech.com/co-develop 2024-11-08T17:36:26+08:00 weekly 0.9 https://srcyrl.prisysbiotech.com/translational-research-center 2024-11-08T17:36:28+08:00 weekly 0.9 https://srcyrl.prisysbiotech.com/download 2024-11-08T18:46:02+08:00 weekly 0.9 https://srcyrl.prisysbiotech.com/fibrosis 2024-09-29T14:45:25+08:00 weekly 0.9 https://srcyrl.prisysbiotech.com/nephrology 2024-11-08T17:36:28+08:00 weekly 0.9 https://srcyrl.prisysbiotech.com/about-us 2024-11-08T17:36:32+08:00 weekly 0.9 https://srcyrl.prisysbiotech.com/contact-us 2023-04-01T22:11:48+08:00 weekly 0.9 https://srcyrl.prisysbiotech.com/newslist-1 2024-11-08T17:36:27+08:00 weekly 0.9 https://srcyrl.prisysbiotech.com/products 2023-04-01T20:46:19+08:00 weekly 1.0 https://srcyrl.prisysbiotech.com/nhp-pharmacology/ 2023-04-01T20:46:21+08:00 weekly 0.9 https://srcyrl.prisysbiotech.com/pk-pd-adme/ 2023-04-01T20:46:23+08:00 weekly 0.9 https://srcyrl.prisysbiotech.com/safety-evaluation/ 2023-04-01T20:46:24+08:00 weekly 0.9 https://srcyrl.prisysbiotech.com/translation-research/ 2023-04-01T20:46:25+08:00 weekly 0.9 https://srcyrl.prisysbiotech.com/biosafety-research/ 2024-04-10T01:10:12+08:00 weekly 0.9 https://srcyrl.prisysbiotech.com/clearpoint/ 2023-04-01T22:10:26+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/nhp-pharmacology/non-human-primate.html 2024-11-08T17:29:02+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/nhp-pharmacology/the-nhp-pharmacology-of-prisys.html 2023-04-01T22:10:29+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/nhp-pharmacology/what-is-a-nhp-study.html 2024-11-08T17:28:47+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/pk-pd-adme/toxicokinetics.html 2024-11-08T17:28:44+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/safety-evaluation/dose-range-finding-test.html 2023-04-01T22:10:30+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/safety-evaluation/single-dose-repeated-dose-toxicity-testing.html 2023-04-01T22:10:38+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/pk-pd-adme/adme.html 2024-11-08T17:28:47+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/nhp-pharmacology/nhp-monkey-disease-models.html 2023-04-01T22:10:40+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/safety-evaluation/toxicology.html 2024-11-08T17:28:46+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/pk-pd-adme/pharmacodynamics.html 2023-04-01T22:10:41+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/translation-research/translational-studies.html 2023-04-01T22:10:42+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/safety-evaluation/new-and-modified-applications.html 2023-04-01T22:10:43+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/safety-evaluation/immunotoxicity.html 2024-11-08T17:29:01+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/biosafety-research/biosafetyresearch.html 2024-11-08T17:28:48+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/translation-research/nhpresources.html 2024-11-08T17:28:58+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/nhp-pharmacology/nhp-asthma-atopic-dermatitis-model.html 2024-11-08T18:44:23+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/nhp-pharmacology/nhp-lung-fibrosis-model.html 2023-04-01T22:10:50+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/nhp-pharmacology/non-human-primate-model-renal-ischemia.html 2024-11-08T17:29:01+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/nhp-pharmacology/nhp-non-alcoholic-steatohepatitis-nash-model.html 2023-04-01T22:10:48+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/nhp-pharmacology/nhp-chronic-obstructive-pulmonary-disease.html 2024-11-08T17:29:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/nhp-pharmacology/hemophilia-a-nonhuman-primates-disease-model.html 2023-04-01T22:10:55+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/nhp-pharmacology/heart-failure-nonhuman-primates-disease-model.html 2023-04-01T22:10:53+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/nhp-pharmacology/coagulation-hemostasis-nonhuman-primates.html 2023-04-01T22:11:01+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/nhp-pharmacology/myopia-hyperopia-nhp-model.html 2023-04-01T22:10:59+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/nhp-pharmacology/embolism-nonhuman-primates-disease-model.html 2023-04-01T22:11:02+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/nhp-pharmacology/amd-nonhuman-primates-disease-model.html 2023-04-01T22:11:04+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/nhp-pharmacology/glaucoma-nonhuman-primates-disease-model.html 2024-11-08T17:30:48+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/nhp-pharmacology/psoriasis-nonhuman-primates-disease-model.html 2023-04-01T22:11:05+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/nhp-pharmacology/uveitis-nonhuman-primates-disease-model.html 2024-11-08T17:30:53+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/nhp-pharmacology/delayed-type-hypersensitivity-dth-nonhuman.html 2023-04-01T22:11:07+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-nhp-disease-model.html 2024-11-08T17:31:11+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/nhp-pharmacology/tdar-nonhuman-primates-disease-model.html 2024-11-08T20:29:37+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/nhp-pharmacology/rheumatoid-arthritis-nhp-model.html 2023-04-01T22:11:10+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/nhp-pharmacology/multiple-sclerosis-nhp-model.html 2024-11-08T18:44:40+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/nhp-pharmacology/mcao-nhp-model.html 2024-11-08T17:30:57+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/nhp-pharmacology/epilepsy-nhp-model.html 2024-11-08T17:31:05+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/nhp-pharmacology/neuropathic-pain-nhp-model.html 2024-11-08T17:28:53+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/pk-pd-adme/pharmacokinetics.html 2024-11-08T17:36:47+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/translation-research/ai-based-nhp-behavior-analysis-system.html 2024-11-08T17:36:50+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/clearpoint/clearpoint-navigation-for-cns-research.html 2024-11-08T17:36:51+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/nhp-pharmacology/parkinson-s-disease-model.html 2024-11-08T18:46:06+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/translation-research/clinical-imaging.html 2024-10-02T01:27:50+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/nhp-pharmacology/immunosuppression-model.html 2024-10-02T01:27:55+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/nhp-pharmacology/a-v-shunt-model.html 2024-10-02T01:28:03+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/nhp-pharmacology/type-1-diabetes-mellitus-model.html 2024-10-02T01:27:56+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/nhp-pharmacology/hyperlipoidemia-model.html 2024-10-02T01:28:04+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/nhp-pharmacology/renal-fibrosis-model.html 2024-11-08T17:37:06+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/nhp-pharmacology/type-2-diabetes-mellitus-model.html 2024-10-02T08:32:58+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/nhp-pharmacology/endometriosis-model.html 2024-12-12T06:19:56+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/clearpoint/nhp-neuroscience.html 2024-12-12T06:19:51+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/clearpoint/convection-enhanced-delivery-ced-technology.html 2025-03-31T05:59:48+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/nhp-pharmacology/atopic-dermatitis-nhp-model.html 2025-03-31T05:59:50+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/nhp-pharmacology/pruritus-nhp-model.html 2025-07-22T01:29:46+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-disease-ibd-nhp-model.html 2025-07-22T01:29:55+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/translation-research/targeted-organ-drug-delivery-platform-in-nhp.html 2025-09-05T03:49:51+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/nhp-pharmacology/aav-synuclein-overexpression-nhp-model.html 2025-09-16T04:59:47+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/nhp-pharmacology/heart-failure-nhp-model.html 2025-09-20T06:14:58+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/nhp-pharmacology/acute-lung-inflammation-ali-nhp-model.html 2025-09-25T03:43:42+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/pk-pd-adme/nose-to-brain-drug-delivery.html 2025-09-29T14:49:50+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/nhp-pharmacology/acute-hemorrhagic-shock-model-nhp-model.html 2025-12-22T12:04:50+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/nhp-pharmacology/retinitis-pigmentosa-rp-nhp-model.html 2026-01-29T15:05:04+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/nhp-pharmacology/liver-fibrosis-model.html 2023-04-01T20:46:21+08:00 weekly 0.9 https://srcyrl.prisysbiotech.com/newslist-714621-1 2023-04-01T22:10:09+08:00 weekly 0.9 https://srcyrl.prisysbiotech.com/newslist-714622-1 2024-07-30T06:52:41+08:00 weekly 0.9 https://srcyrl.prisysbiotech.com/newslist-818824-1 2023-04-01T22:10:15+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/meetprisys-sot2023-66156075.html 2023-04-01T22:10:15+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/the-construction-of-prisys-shanghai-nhp-r-d-ce-66156076.html 2023-04-01T22:10:19+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/do-we-need-further-studies-for-pain-assessment-66156078.html 2023-04-01T22:10:17+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/prisys-celebrating-world-wildlife-day-66156079.html 2023-04-01T22:10:17+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/prisys-sot2023-66156080.html 2023-04-01T22:10:19+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/supporting-women-s-health-a-look-into-endomet-66156081.html 2023-04-01T22:10:21+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/prisys-biotech-non-human-primate-pharmacology-66156082.html 2023-04-01T22:10:21+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/gene-therapy-nhp-model-66156083.html 2023-04-01T22:10:22+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/top-10-popular-questions-related-to-gene-thera-66156084.html 2023-04-01T22:10:26+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/dmpk-study-for-gene-therapy-66156086.html 2023-04-06T22:28:12+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/gene-therapy-toxicology-66268872.html 2026-04-08T00:33:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/world-parkinsons-disease-day-67245183.html 2026-04-08T00:33:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/nhp-effectively-in-gene-therapy-67245184.html 2026-04-08T00:33:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/unlocking-the-potential-of-nonhuman-primates-67245185.html 2026-04-08T00:33:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/unleashing-the-therapeutic-potential-67245191.html 2026-04-08T00:33:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/maximizing-crispr-cas9-research-efficiency-wit-67245192.html 2026-04-08T00:33:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/celebrating-world-day-for-laboratory-animals-67245201.html 2026-04-08T00:33:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/how-nonhuman-primates-can-revolutionize-sirna-67245202.html 2026-04-08T00:33:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/maximizing-sirna-pharmacology-efficiency-67245203.html 2023-06-10T20:06:03+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/gene-therapy-shines-with-new-approvals-for-rar-68324808.html 2023-06-10T20:06:02+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/revolutionizing-drug-discovery-nhp-68324809.html 2023-06-10T20:06:02+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/meet-prisys-biotech-at-70th-jalas-68324810.html 2023-06-10T20:06:44+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/why-you-should-care-about-non-human-primates-68324812.html 2023-06-19T01:37:16+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/an-optimal-animal-model-of-ischemic-stroke-est-68567822.html 2026-04-08T00:33:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/prisys-biotech-showcases-non-human-primate-mod-69120779.html 2023-07-11T06:05:55+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/what-are-lipid-nanoparticles-for-gene-therapy-69120781.html 2026-04-08T00:33:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/the-promising-future-of-aav-gene-therapy-in-no-69120782.html 2023-07-11T06:05:54+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/prisys-biotech-invites-you-to-participate-in-t-69120783.html 2023-07-11T06:05:55+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/immunotoxicity-test-drug-safety-evaluation-pr-69120784.html 2023-07-11T06:05:59+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/how-aav-gene-therapy-can-save-your-vision-the-69120786.html 2023-07-19T04:49:17+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/large-animal-experiment-public-service-platfor-69373065.html 2023-07-19T04:49:09+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/how-to-lose-weight-and-control-diabetes-with-g-69373072.html 2023-07-19T04:49:10+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/how-china-monkey-help-to-conduct-preclinical-r-69373075.html 2023-07-19T04:50:03+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/what-is-the-efficiency-of-rnai-69373083.html 2023-08-03T18:41:09+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/prisys-biotechnology-a-leader-in-nhp-cns-dise-69724148.html 2023-08-03T18:41:12+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/key-research-points-of-adc-drug-pk-69724181.html 2023-09-14T14:01:29+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/method-for-establishing-a-cynomolgus-monkey-mo-71001879.html 2023-09-14T14:01:29+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/preclinical-pharmacology-evaluation-of-oncolyt-71001880.html 2023-09-14T14:01:30+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/0-71001881.html 2023-09-14T14:01:30+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/prisys-providing-high-quality-animal-experime-71001882.html 2023-09-14T14:01:32+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/pharmacology-main-parameters-and-significance-71001883.html 2023-09-14T14:01:29+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/pharmacokinetics-research-strategies-and-case-71001884.html 2026-04-08T00:33:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/prisys-biotech-invites-you-to-attend-sapa-chin-72324950.html 2026-04-08T00:33:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/meet-prisys-biotech-at-the-society-for-neurosc-72324951.html 2026-04-08T00:33:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/world-alzheimer-s-day-the-challenges-and-sol-72324953.html 2026-04-08T00:33:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/world-stroke-day-focus-on-ischemic-stroke-an-72324955.html 2023-11-07T20:00:53+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-macaque-animal-mod-72333109.html 2023-11-21T17:00:10+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/exhibition-review-prisys-biotech-shines-at-t-72680475.html 2023-12-04T23:20:27+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/non-human-primates-a-brief-introduction-to-th-73013072.html 2026-04-08T00:33:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/guidelines-for-lifetime-use-of-nonhuman-primat-73538599.html 2026-04-08T00:33:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/how-ultrasound-guided-liver-biopsy-enhances-ma-73539172.html 2024-01-16T17:33:31+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/revolutionizing-cns-drug-delivery-prisys-and-74248912.html 2024-01-31T06:25:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/elevating-nucleic-acid-therapeutics-through-cu-74802535.html 2026-04-08T00:33:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/prisys-advancing-animal-experimentation-throu-74885702.html 2024-11-08T17:36:31+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/nonhuman-primate-study-newsletter-2024-q-75182768.html 2024-02-22T15:28:31+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/non-clinical-pharmacodynamics-research-an-ess-75182769.html 2024-03-29T13:45:28+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/prisys-achieves-full-accreditation-from-aaalac-76218835.html 2024-04-27T10:01:41+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/innovative-solutions-for-advancing-respiratory-77066219.html 2024-11-08T17:36:32+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/prisys-biotech-2024-q2-newsletter-77759363.html 2024-05-26T02:16:43+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/mri-guided-large-animal-central-nervous-system-77774624.html 2024-07-20T02:41:25+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/intra-cerebrovascular-stroke-ich-model-prisys-79193064.html 2024-11-08T17:36:36+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/direct-delivery-of-oligonucleotide-drugs-to-th-79193086.html 2024-07-20T02:41:33+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/advancing-immunology-and-inflammation-research-79193087.html 2024-07-20T02:41:36+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/nhp-asthma-model-79193088.html 2024-11-08T17:36:39+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/non-na-ve-nhps-in-preclinical-trials-a-cost-e-79193089.html 2024-11-08T17:36:39+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/prisys-nhp-models-immunology-inflammatio-79419215.html 2024-11-08T17:36:36+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/cynomolgus-monkey-in-ophthalmic-drug-research-79419216.html 2024-11-08T17:36:41+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/revolutionizing-cns-drug-development-prisys-b-79419218.html 2024-11-08T17:36:41+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/pk-strategies-of-pdc-79546426.html 2024-11-08T17:36:46+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/nonclinical-safety-evaluation-of-ocular-drug-d-79546427.html 2024-08-03T05:40:52+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/the-role-of-aav-in-gene-therapy-immune-respon-79546428.html 2024-08-03T05:40:56+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/reducing-the-use-of-nonhuman-primates-in-noncl-79546429.html 2024-08-03T05:40:51+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/optimized-nonclinical-immunogenicity-evaluatio-79546430.html 2024-08-03T05:40:58+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/clinical-pathology-data-interpretation-challen-79546431.html 2024-08-03T05:41:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79546432.html 2024-08-03T05:41:09+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79546433.html 2024-08-03T05:40:58+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/preclinical-animal-studies-2-routes-and-vo-79546434.html 2024-08-03T05:41:13+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/how-to-conduct-preclinical-pharmacology-toxico-79546435.html 2024-11-08T17:36:42+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/integrating-cns-safety-evaluation-into-79546436.html 2024-08-03T05:41:27+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/advancing-cns-and-cgt-research-prisys-biotech-79546443.html 2024-08-03T05:41:22+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/non-human-primate-cerebrospinal-fluid-collecti-79546445.html 2024-11-08T18:45:58+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/considerations-for-interpreting-clinical-patho-79546446.html 2024-08-03T05:41:30+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/how-to-evaluate-preclinical-pharmacological-ef-79546447.html 2024-08-03T05:41:06+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/preclinical-animal-studies-1-animal-specie-79546448.html 2024-08-03T05:41:40+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/significance-principles-and-requirements-of-79546449.html 2024-08-03T05:42:16+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/application-prospects-of-gene-drugs-based-on-l-79546478.html 2024-08-03T05:42:13+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/insight-into-the-sensory-and-behavioral-traits-79546479.html 2024-08-03T05:42:16+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/key-points-in-designing-strategies-for-non-79546480.html 2024-08-03T05:42:02+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/nonclinical-study-evaluation-q-a-79546481.html 2024-08-03T05:42:18+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/advancing-sirna-therapeutics-overcoming-chall-79546482.html 2024-08-03T05:42:23+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/liver-toxicity-as-a-key-concern-for-sirna-drug-79546483.html 2024-08-03T05:42:20+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/how-to-evaluate-the-safety-of-skin-products-be-79546484.html 2024-08-03T05:42:21+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/the-significant-role-of-experimental-monkeys-i-79546485.html 2024-08-03T05:42:20+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/revolutionizing-metabolic-disease-treatment-a-79546486.html 2024-08-03T05:42:35+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/the-vital-role-of-experimental-monkeys-in-adva-79546487.html 2024-08-03T05:42:40+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/group-housing-guidelines-for-laboratory-monkey-79546488.html 2024-11-08T17:36:43+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/understanding-macaca-fascicularis-cynomolgus-79546489.html 2024-08-03T05:43:00+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/how-to-develop-new-drugs-faster-and-safer-a-g-79546490.html 2024-08-03T05:42:59+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/how-to-deliver-biologics-to-the-brain-79546491.html 2024-11-08T17:36:47+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/the-main-factors-considered-in-woe-analysis-79546492.html 2024-11-08T17:36:45+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/the-importance-of-translational-medicine-resea-79546493.html 2024-08-03T05:42:59+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/how-drugs-move-and-change-in-our-bodies-a-bri-79546494.html 2024-08-03T05:43:03+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/prisys-biotechnology-novel-lipid-nanoparticle-79546495.html 2024-08-03T05:43:05+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/chinese-scientists-offers-new-strategies-to-re-79546496.html 2024-08-03T05:43:19+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/mrna-a-powerful-and-versatile-tool-for-fighti-79546497.html 2024-08-03T11:53:59+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/reflections-on-non-clinical-pharmacology-studi-79550944.html 2024-08-03T11:56:17+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/factors-to-consider-for-the-immunogenicity-of-79550950.html 2024-08-03T11:56:23+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79550951.html 2024-08-03T11:56:26+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79550952.html 2026-04-08T00:33:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/brief-introduction-about-biological-analysis-o-79550953.html 2024-08-03T11:56:24+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/pharmacodynamic-pd-evaluation-of-gene-therap-79550954.html 2024-11-08T17:36:46+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/mrna-based-therapies-past-79550955.html 2024-08-03T11:56:29+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/mrna-based-therapies-future-and-challenges-79550956.html 2024-08-03T11:56:30+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/mrna-based-therapies-present-79550957.html 2024-08-03T11:56:31+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/lcms-preclinical-bioanalysis-of-lnp-based-gene-79550959.html 2024-08-07T08:44:22+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/advancements-in-cns-research-ced-imri-79656465.html 2024-10-02T01:27:22+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/advanced-cns-delivery-techniques-in-cynomolgus-81266604.html 2024-10-02T01:27:28+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/cynomolgus-monkey-chronic-kidney-disease-model-81266605.html 2024-11-08T17:36:53+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/convection-enhanced-delivery-81266606.html 2024-10-02T01:27:34+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/intranasal-administration-in-animal-studies-81266607.html 2024-10-02T01:27:33+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/human-disease-animal-models-81266608.html 2024-11-08T17:36:51+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/the-importance-of-preclinical-pharmacodynamics-81266609.html 2024-10-02T01:27:40+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/china-experimental-monkey-industry-81266611.html 2024-10-02T01:27:41+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/innovations-in-pain-evaluation-ai-driven-beha-81266612.html 2024-10-02T01:27:40+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/rtimri-for-parkinsons-disease-81266613.html 2024-10-02T01:27:54+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/dmpk-evaluation-of-central-nervous-system-cns-81266614.html 2024-10-02T01:27:39+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/compartment-pk-model-81266615.html 2024-10-02T01:27:56+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/cynomolgus-monkey-mcao-model-81266616.html 2024-10-02T01:27:45+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/animal-models-of-human-diseases-81266618.html 2026-04-08T00:33:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/advances-in-mrna-pulmonary-delivery-systems-an-82255209.html 2026-04-08T00:33:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/understanding-the-dmpk-of-adc-drugs-82805477.html 2026-04-08T00:33:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/progress-in-the-development-of-nucleic-acid-dr-82805479.html 2026-04-08T00:33:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/comprehensive-preclinical-safety-evaluation-of-82805480.html 2026-04-08T00:33:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/pharmacodynamics-evaluation-of-adcs-82805481.html 2026-04-08T00:33:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/pharmacokinetics-evaluation-of-antibody-drug-c-82805482.html 2026-04-08T00:33:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/pharmacokinetic-pk-considerations-for-centra-82805483.html 2026-04-08T00:33:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/prisys-biotech-establishes-cynomolgus-monkey-p-82805484.html 2026-04-08T00:33:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/2024-nobel-prize-in-physiology-or-medicine-82805490.html 2026-04-08T00:33:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/comprehensive-non-human-primate-models-for-ren-82821189.html 2024-12-10T21:32:15+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/ocular-toxicity-studies-of-eye-drops-drug-exp-83135764.html 2024-12-10T21:32:19+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/real-time-intraoperative-mri-navigation-suppo-83135767.html 2024-12-10T21:32:20+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/drug-delivery-strategies-for-brain-diseases-83135772.html 2025-01-16T08:53:02+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/minipig-as-nonclinical-large-animal-84132231.html 2025-01-16T08:53:03+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/nasal-to-brain-n2b-drug-delivery-84132232.html 2025-01-16T08:52:54+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/prisys-annual-report-2024-advancing-nhp-model-84132233.html 2025-01-16T08:53:08+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/nonclinical-drug-development-guide-toxicity-84132234.html 2025-01-29T08:23:09+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/parkin-gene-deficiency-monkey-model-reveals-ne-84132235.html 2025-01-16T08:53:17+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/the-critical-role-of-animal-models-in-human-di-84132236.html 2025-01-16T08:53:18+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/animal-models-for-atopic-dermatitis-84132237.html 2025-01-16T08:53:22+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/advancing-rheumatoid-arthritis-ra-research-w-84132238.html 2025-01-16T08:53:26+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/potential-routes-for-biologics-to-brain-84132239.html 2026-04-08T00:33:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/meet-prisys-in-2025-us-roadshow-17256401773372416.html 2026-04-08T00:33:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/selecting-the-ideal-non-human-primate-for-toxi-17256402017559552.html 2026-04-08T00:33:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/systemic-lupus-erythematosus-sle-and-the-rol-17293031197533184.html 2026-04-08T00:33:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/animal-models-challenges-and-applications-in-17293031207642112.html 2025-03-31T05:59:05+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/non-human-primate-model-for-rheumatoid-arthrit-17293031225828352.html 2025-03-31T05:59:02+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/integration-of-pharmacokinetics-and-pharmacody-17293031300441088.html 2025-03-31T05:59:01+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/animal-brain-stereotactic-instruments-17293031300736000.html 2025-03-31T05:59:15+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/animal-models-for-womens-health-17293031401022464.html 2025-03-31T05:59:18+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-monkey-psoriasis-m-17293031452353536.html 2026-04-08T00:33:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/nonclinical-pharmacodynamic-research-17293031480157184.html 2025-03-31T05:59:38+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/membranous-nephropathy-model-17293031514121216.html 2025-03-31T05:59:05+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/what-does-proof-of-concept-poc-in-drug-devel-17293031597155328.html 2025-03-31T05:59:41+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/microbial-testing-and-its-impact-on-nhp-17293031600219136.html 2026-04-08T00:33:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/liver-biopsy-a-crucial-technique-in-large-ani-17293031624254464.html 2025-03-31T05:59:27+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/world-obesity-day-nhp-metabolic-models-17293031719543808.html 2025-03-31T05:59:27+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/pharmacokinetics-of-inhaled-drugs-17293031736452096.html 2025-03-31T05:59:35+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/cynomolgus-monkey-endometriosis-model-17293031791764480.html 2026-04-08T00:33:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/animal-models-for-in-vivo-testing-1-establi-17293031800218624.html 2025-03-31T05:59:50+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/nonclinical-immunotoxicity-assessment-strateg-17293031888577536.html 2025-04-05T20:00:57+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/targeting-interleukin-31-autoimmune-disease-17300919239894016.html 2025-06-01T08:46:41+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/intracerebroventricular-icv-injection-17380978395489280.html 2026-04-08T00:33:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/intrathecal-it-injection-a-direct-cns-deliv-17380979447604224.html 2026-04-08T00:33:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/nhp-inhalation-studies-for-biologics-prisys-17380980104094720.html 2026-04-08T00:33:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/aso-pharmacokinetics-absorption-17380980297114624.html 2026-04-08T00:33:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/preclinical-pk-pd-studies-nhp-models-17380982663439360.html 2026-04-08T00:33:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/pharmacokinetics-pk-key-parameters-17380990154204160.html 2026-04-08T00:33:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/designing-animal-studies-key-considerations-f-17380990760887296.html 2026-04-08T00:33:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/intracerebral-icm-injection-precision-targe-17380991462056960.html 2025-06-01T09:00:43+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/advancing-parkinson-s-disease-research-with-th-17380992172041216.html 2026-04-08T00:33:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/advanced-preclinical-inhalation-studies-techn-17380998648013824.html 2026-04-08T00:33:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/atopic-dermatitis-how-cynomolgus-monkey-model-17381002449265664.html 2026-04-08T00:33:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/asthma-research-why-non-human-primate-models-17381009589855232.html 2025-07-22T01:30:13+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/prisys-biotech-s-nhp-atopic-dermatitis-model-f-17452729772073984.html 2025-07-22T01:30:16+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/advancing-atopic-dermatitis-research-prisys-b-17452729829614592.html 2025-07-22T01:30:11+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/cynomolgus-monkey-pain-models-17452729843885056.html 2025-07-22T01:30:17+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/prisys-biotech-s-advanced-dsa-and-imri-for-hem-17452729937585152.html 2025-07-22T01:30:38+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/guiding-principles-for-animal-species-selectio-17452730577839104.html 2025-07-22T01:31:04+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/nhp-model-platforms-to-support-drug-developmen-17452731376755712.html 2025-07-22T01:31:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/nhp-pain-models-accelerating-analgesic-drug-d-17452731441357824.html 2025-07-22T01:31:10+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/key-considerations-for-dosing-volume-17452731499078656.html 2025-07-22T01:31:32+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/respiratory-therapies-prisys-biotech-s-integr-17452731910628352.html 2025-07-22T01:33:41+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/a-guide-to-anti-drug-antibody-ada-assessment-17452733820298240.html 2025-07-22T01:35:55+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/prisys-biotech-2025-mid-year-review-17452734921712640.html 2025-07-22T01:45:44+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/engineered-exosomes-revolutionizing-drug-deli-17452745827492864.html 2025-09-05T03:47:29+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/pruritus-research-il-31-nhp-itch-model-17516536087520256.html 2025-09-05T03:47:44+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/nhp-acute-hemorrhage-model-17516536169997312.html 2025-09-05T03:48:01+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/preclinical-dosing-guidelines-iv-po-volume-17516536367899648.html 2025-09-05T03:48:11+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/serum-vs-plasma-choosing-the-optimal-matrix-17516536372044800.html 2025-09-05T03:47:59+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/nhp-copd-model-17516536392033280.html 2025-09-05T03:48:10+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/nhp-pain-models-for-translational-drug-discove-17516536486683648.html 2025-09-16T04:59:49+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/brain-targeted-drug-delivery-17532218212328448.html 2025-09-16T04:59:50+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/idiopathic-pulmonary-fibrosis-ipf-nhp-model-17532218226762752.html 2025-09-16T04:59:50+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/the-importance-of-administration-volume-17532218303030272.html 2025-09-16T04:59:51+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/cynomolgus-monkey-biodistribution-study-17532218303308800.html 2025-09-16T04:59:50+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/adc-drug-development-translational-pk-pd-fra-17532218309813248.html 2025-09-16T04:59:55+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/nhp-models-for-hematology-and-stroke-17532218367386624.html 2025-09-16T05:00:03+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/meet-prisys-biotech-at-upcoming-eu-roadshow-17532218472375296.html 2025-09-20T06:14:51+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/cynomolgus-rhesus-monkey-models-prisys-bio-17537924830815232.html 2026-04-08T00:33:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/nhp-based-pharmacology-and-pharmacodynamic-17551230904034304.html 2025-12-11T14:42:44+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/shr-2004-a-breakthrough-in-vte-prevention-for-17654534889104384.html 2025-12-11T14:42:43+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/nasal-to-brain-n2b-delivery-technology-for-c-17654534908650496.html 2025-12-11T14:43:00+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/nhp-ai-based-behavioral-analysis-17654534975595520.html 2025-12-11T14:42:54+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/cold-allodynia-pain-model-in-cynomolgus-monkey-17654535010214912.html 2025-12-11T14:42:59+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/pk-study-targeted-drug-delivery-17654535050863616.html 2025-12-11T14:42:56+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/th17-driven-nhp-immunology-models-17654535076324352.html 2025-12-11T14:42:59+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/mri-guided-intracerebral-drug-delivery-17654535098131456.html 2025-12-11T14:42:58+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/nhp-renal-biopsy-17654535211574272.html 2025-12-11T14:43:02+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/ai-based-nhp-behavioratlas-system-3d-behavi-17654535238247424.html 2025-12-11T14:43:05+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/nhp-respiratory-disease-models-and-airway-drug-17654535268819968.html 2025-12-11T14:44:10+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/rfp-template-for-nhp-studies-17654536341742592.html 2025-12-22T12:04:59+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/translational-car-t-evaluation-in-vitro-17669948186846208.html 2025-12-22T12:04:56+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/high-precision-drug-delivery-and-ai-driven-nhp-17669948194300928.html 2025-12-22T12:04:58+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/cns-drug-candidates-in-preclinical-study-17669948222628864.html 2025-12-22T12:05:02+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/parkinsons-disease-preclinical-models-17669948347409408.html 2025-12-22T12:05:09+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/how-to-choose-a-reliable-preclinical-cro-key-17669948347933696.html 2025-12-22T12:05:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/one-to-multi-compartment-pk-models-17669948393137152.html 2025-12-22T12:05:15+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/hdm-seb-induced-atopic-dermatitis-atd-model-17669948404966400.html 2025-12-22T12:05:11+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/ai-driven-markerless-3d-behavioral-analysis-17669948450874368.html 2025-12-22T12:05:12+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/lps-induced-acute-lung-inflammation-ali-nhp-17669948527453184.html 2026-01-29T15:05:00+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/non-human-primate-mash-associated-liver-fibros-17723920485999616.html 2026-01-29T15:05:03+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/multi-endpoint-pain-assessment-the-future-17723920522748928.html 2026-01-29T15:05:08+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/2025-recap-how-prisys-is-redefining-translati-17723920554599424.html 2026-01-29T15:05:03+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/non-human-primate-models-are-critical-cns-17723920559105024.html 2026-01-29T15:05:07+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/imri-guided-brain-drug-delivery-17723920623526912.html 2026-01-29T15:05:14+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/emotional-memory-chronic-pain-nhp-models-17723920636978176.html 2026-01-29T15:05:12+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/analgesics-fail-in-preclinical-measure-pain-17723920654033920.html 2026-01-29T15:05:08+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/uric-acid-metabolism-in-humans-vs-monkeys-17723920660751360.html 2026-01-29T15:05:34+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/blood-sampling-time-point-in-pharmacokinetic-17723920846693376.html 2026-01-29T15:05:30+08:00 weekly 0.8 https://srcyrl.prisysbiotech.com/news/pk-statistical-analysis-nca-parameters-guide-17723920919241728.html